VerifiedEvidence: highv1.0.0

Social Return on Investment

A framework extending conventional return on investment analysis by monetising broader social, environmental, and health outcomes alongside financial returns.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept

Theoretically, Social Return on Investment (SROI) is an evaluation framework that measures the social, economic and environmental value created by an intervention relative to the resources invested. It is founded on welfare economics, cost-benefit analysis and stakeholder value theory, extending conventional financial return on investment by assigning monetary values to outcomes that are not traded in markets. In health economics, SROI is used to evaluate interventions that generate broader societal impacts beyond direct healthcare outcomes.

Mathematically, Social Return on Investment is represented as the ratio of the present value of total social value created to the total value of the investment. Social value is estimated by identifying outcomes, assigning monetary proxies, adjusting for attribution, deadweight, displacement and drop-off where appropriate, and discounting future benefits to present values.

In practice, SROI is implemented by identifying stakeholders, developing an impact pathway, measuring outcomes, assigning financial proxies to social and environmental effects and calculating the discounted value of benefits relative to investment costs. It is commonly applied to public health programmes, social prescribing, community health initiatives and preventive interventions that generate benefits across multiple sectors.


Purpose

Used to quantify the total social value created by a healthcare or public health intervention relative to the resources invested, incorporating outcomes beyond direct financial returns.


Mathematical Formulae

Primary Formula

SROI = Present Value of Social Benefits / Total Investment

Supporting Formulae

Present value of social benefits:

PV = ????? SB? / (1 + r)?

where:

  • SB? = adjusted social benefit in period t
  • r = social discount rate
  • T = evaluation time horizon

Net social value:

Net Social Value = Present Value of Social Benefits ? Total Investment

Related Mathematical Methods

  • Cost-Benefit Analysis
  • Present Value
  • Discounting
  • Social Discount Rate
  • Return on Investment
  • Sensitivity Analysis

Example

A community-based diabetes prevention programme requires an investment of �500,000. After adjusting for deadweight, attribution and displacement, the discounted value of improved health, productivity and reduced social care costs is estimated at �2,250,000.

SROI = 2,250,000 / 500,000 = 4.5

The programme generates an SROI ratio of 4.5:1, indicating that every �1 invested produces an estimated �4.50 of social value.


Excel Implementation

FunctionExample FormulaHealth Economics Application
NPV=NPV(3.5%,B2:B10)Calculates the present value of future social benefits
Division=C2/D2Calculates the SROI ratio from discounted benefits and investment costs
SUM=SUM(B2:B10)Aggregates adjusted social benefits
IF=IF(E2>1,""Positive Social Return"",""Negative Social Return"")Interprets the SROI result

VBA (Optional)

Automate stakeholder outcome valuation, discount future social benefits and generate Social Return on Investment reports for multiple intervention scenarios.


Sources

  • Nicholls J, Lawlor E, Neitzert E, Goodspeed T. A Guide to Social Return on Investment. Office of the Third Sector.
  • Social Value International. A Guide to Social Return on Investment.
  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  • HM Treasury. The Green Book: Central Government Guidance on Appraisal and Evaluation.
  • Boardman AE, Greenberg DH, Vining AR, Weimer DL. Cost-Benefit Analysis: Concepts and Practice.

Library

Publications

1
  • Guidance

    NICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values — Brazier, Rowen, TSD 11 ed., 2011 (NICE Decision Support Unit (University of Sheffield))

    Guidance on alternatives to EQ-5D — including SF-6D, HUI, condition-specific preference-based measures, direct valuation and vignette methods — for generating health-state utility values.

Frequently Asked Questions (6)

  • What is social return on investment?

    A framework extending conventional return on investment analysis by monetising broader social, environmental, and health outcomes alongside financial returns.

    Source: Nicholls et al. 2009

  • How is social return on investment calculated?

    Stakeholders affected by an activity are identified, the outcomes each experiences are established, and a monetary value is attached to every outcome including those with no market price. Adjustments are then made for what would have happened anyway, for outcomes attributable to other causes, for effects displaced from elsewhere, and for the tendency of outcomes to decline over time. The adjusted value is discounted and divided by the investment, producing a ratio expressed as value created per unit invested. The process is normally documented in a report setting out the stakeholder map and the value attached to each outcome, so the ratio can be traced back to its components.

    Source: Nicholls et al. 2009

  • What adjustments does social return on investment require?

    Four are standard and each reduces the headline figure. Deadweight removes the proportion of the outcome that would have occurred without the activity. Attribution removes the share caused by other organisations or factors. Displacement removes benefit that simply moved from somewhere else rather than being created. Drop-off reduces outcomes persisting into later years. Omitting any of these inflates the ratio substantially, and analyses differ widely in how rigorously they are applied. Reporting the ratio before and after adjustment is therefore more informative than the final figure alone, since it shows how much of the headline claim survived scrutiny.

    Source: Nicholls et al. 2009

  • How does social return on investment differ from cost-benefit analysis?

    The underlying arithmetic is much the same, since both monetise outcomes and compare them against cost. The differences are in emphasis and process: social return on investment involves stakeholders directly in identifying and valuing outcomes, gives more weight to effects on individuals and communities that conventional appraisal treats as intangible, and is normally conducted by or for the delivering organisation rather than by an independent appraiser. The reporting standard is also less prescriptive. The two also differ in audience, since one is generally produced to inform an allocation decision and the other to demonstrate value to funders and commissioners.

    Source: Boardman et al. 2011

  • What criticisms are made of social return on investment?

    That the monetary values attached to social outcomes are frequently borrowed from unrelated studies with little assessment of whether they transfer. That the adjustments are applied inconsistently, so published ratios are not comparable. That stakeholder involvement in valuation, while democratising, introduces incentives for those benefiting to value outcomes generously. And that the resulting figures circulate as headline claims without the assumptions that produced them, which is the same problem that afflicts return on investment generally. A further difficulty is that the framework does not require a comparator, so a favourable ratio establishes that value exceeded cost without establishing that an alternative use would not have produced more.

    Source: Drummond et al. 2015

  • Where is social return on investment appropriate?

    Where an activity produces effects across several domains that no single outcome measure captures, and where the audience requires a monetary summary. It suits community and voluntary sector programmes, public health interventions with social as well as health effects, and cases where the purpose is to demonstrate value to funders rather than to inform a comparative allocation decision. It is not a substitute for cost-effectiveness analysis where the decision concerns competing uses of a health budget. Where it is used alongside a conventional evaluation rather than in place of one, the wider outcomes it captures can inform a judgement that the narrower analysis leaves out.

    Source: Drummond et al. 2015

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 4 Aug 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EE-CBA-047

Stable URI · Machine-readable · Resolvable · CC BY 4.0